Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Infections
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Board
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Artificial Intelligence
Letter to Editor, Bone Soft Tissue
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Adolescent and Young Adult
Original Article, Artificial Intelligence
Original Article, Bone Soft Tissue
Original Article, Breast
Original Article, Gastro Intestinal
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Gynaecology
Original Article, Head Neck
Original Article, Infections
Original Article, Lung
Original Article, Molecular
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Gastro Intestinal
Review Article, Haematological
Review Article, International
Review Article, Nervous System
Review Consensus, Geriatric Oncology
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Infections
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Board
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Artificial Intelligence
Letter to Editor, Bone Soft Tissue
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Adolescent and Young Adult
Original Article, Artificial Intelligence
Original Article, Bone Soft Tissue
Original Article, Breast
Original Article, Gastro Intestinal
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Gynaecology
Original Article, Head Neck
Original Article, Infections
Original Article, Lung
Original Article, Molecular
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Gastro Intestinal
Review Article, Haematological
Review Article, International
Review Article, Nervous System
Review Consensus, Geriatric Oncology
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Letter to Editor
Artificial Intelligence
15 (
2
); 198-201
doi:
10.25259/SAJC_1_2026

Using artificial intelligence language models to answer common patient queries about cervical cancer screening

Department of Medicine, St. Martinus University, Pontiac, United States of America
Author image
Corresponding author: Shree Vidya Umashankar, Department of Medicine, St. Martinus University, 461 W Huron St, Pontiac, 48341, United States of America. shreevidya4umashankar@gmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Umashankar SV. Using artificial intelligence language models to answer common patient queries about cervical cancer screening. South Asian J Cancer. 2026;15:198-201. doi: 10.25259/SAJC_1_2026

Dear Editor,

Cancer is among the leading causes of mortality, with viral infections contributing 15-20% of all human cancers.[1] Cervical cancer continues to remain the fourth leading cause of cancer-related death and the most commonly diagnosed cancer among women worldwide.[2] The leading etiological factor in cervical cancer is the human papillomavirus (HPV) infection.[2] Nonetheless, in developing countries, HPV infection rates continue unabated. Low socioeconomic status, lack of population awareness, and inadequately implemented screening and vaccine programs may be the contributing factors.[1] To address this issue, a multifaceted approach with improvement in access to care and improvements in treatment should be done alongside primary and secondary prevention.[3] This letter aims to provide a critical perspective on the use of artificial intelligence (AI) language models in patient education, rather than present original research data.

A division of AI language models includes generative AI, such as ChatGPT, which creates new data built on patterns and structures learned from existing data.[4] ChatGPT has rapidly become a worldwide trend, providing well-structured responses to diverse queries. However, its use in clinical practice is yet to be evaluated due to a lack of studies.[5] To explore this, I initiated a conversation with ChatGPT with some common patient queries about cervical cancer screening. Table 1 provides illustrative examples of ChatGPT responses to common patient queries about cervical cancer screening, highlighting its potential role in patient education.

Table 1: AI-generated responses to frequently asked questions on cervical cancer screening
Patient questions ChatGPT response
What is a Pap smear? A Pap smear (also called a Pap test) is a medical procedure used to screen for cervical cancer in women. It helps detect abnormal cells on the cervix (the lower part of the uterus that opens into the vagina) that may develop into cancer if left untreated.
How it works:
During the procedure:
  1. A doctor inserts a speculum into the vagina to widen it.

  2. A small brush or spatula is used to gently collect cells from the cervix.

  3. The collected cells are sent to a lab, where they’re examined under a microscope.


What it detects:
  • Precancerous changes in cervical cells (called cervical dysplasia)

  • Human papillomavirus (HPV) infection (if done with an HPV test)

  • Cervical cancer (in its early stages)


Who should get it:
  • Women typically start getting Pap smears at age 21.

  • From ages 21 to 65, it’s recommended every 3 years (or every 5 years if combined with an HPV test), unless advised otherwise by a doctor.


Why it’s important:
Regular Pap smears can catch early signs of cervical cancer, when treatment is most effective, often before any symptoms appear.
Let me know if you want to know about the difference between a Pap smear and an HPV test, or how to prepare for one.
When should I start getting Pap smears? You should typically start getting Pap smears at age 21, regardless of when you became sexually active.
Here's a general guideline:
  • Ages 21–29: Get a Pap smear every 3 years, as long as the results are normal.

  • Ages 30–65: You can choose one of the following options:

    • -Pap smear every 3 years, or

    • -HPV test every 5 years, or

    • -Co-testing (Pap + HPV) every 5 years

  • Over age 65: You may stop screening if you've had several normal results in a row and no history of serious cervical issues.


Special situations:
You may need more frequent Pap smears if you:
  • Have a history of abnormal Pap results

  • Are HIV positive

  • Have a weakened immune system

  • Were exposed to DES (diethylstilbestrol) before birth


Let me know if you'd like help understanding HPV or what to expect during your first Pap smear.
What is the difference between a Pap smear and an
HPV test?
Great question! While both the Pap smear and the HPV test are used to screen for cervical cancer, they look for different things and may be used together or separately, depending on your age and health history.
Pap smear (Pap test)
  • What it checks: Looks for abnormal (precancerous or cancerous) cells on the cervix.

  • Purpose: Detects early cell changes that may lead to cervical cancer if untreated.

  • How it’s done: A sample of cervical cells is collected and examined under a microscope.

  • When it's used: Starting at age 21, usually every 3 years if results are normal.


HPV test
  • What it checks: Looks for the presence of high-risk types of human papillomavirus (HPV)—especially types 16 and 18, which are strongly linked to cervical cancer.

  • Purpose: Identifies a viral infection that can cause abnormal cell changes.

  • How it’s done: Often uses the same sample of cervical cells as the Pap test.

  • When it’s used: Typically done from age 30 and up, either:

    • - Alone (every 5 years), or

    • - Along with a Pap smear (co-testing)


Summary of differences
Feature Pap smear HPV test
Detects Abnormal cervical cells High-risk HPV virus
Main purpose Identify early signs of cancer Identify the risk of developing cancer
Age group Starts at age 21 Usually starts at age 30
Frequency Every 3 years (if normal) Every 5 years (if normal)
Can be combined? Yes, often combined with the Pap test
Let me know if you want to talk about HPV vaccines, how to prepare for the tests, or what results might mean.
Is it harmful if I skip screening? Yes, skipping cervical screening (like the Pap smear or HPV test) can be harmful, because it increases your risk of not detecting cervical cancer early — when it’s easiest to treat and cure. Here's why skipping screening is risky:
1. Cervical cancer often has no symptoms in the early stages
• ou might feel completely fine even if abnormal cells are developing.
• By the time symptoms appear (like bleeding or pelvic pain), the cancer may be more advanced.
2. HPV is common and often silent
• Most cervical cancers are caused by high-risk HPV types.
• HPV infections usually don't cause symptoms, but some persist and lead to precancerous changes.
3. Early detection = highly treatable
• When abnormal cells or early-stage cancer are found, treatment is very effective.
• If left untreated, those cells can progress to invasive cancer over time.
Regular screening helps:
• Catch problems before they turn into cancer
• Reduce your lifetime risk of cervical cancer
• Provide peace of mind if results are normal
When skipping might be okay (with a doctor’s guidance):
• You're over 65 with a long history of normal results
• You've had a total hysterectomy for non-cancer reasons
• You're in a low-risk group, as determined by your doctor
Let me know if you want help understanding how often you need screening based on your history, or if you'd like a checklist for what to expect during the test.
Do I need screening if I have had the HPV vaccine? Yes, even if you’ve had the HPV vaccine, you still need regular cervical cancer screening (Pap smears and/or HPV tests).
Why?
1. The HPV vaccine doesn’t cover all cancer-causing HPV types
• The most common vaccines (like Gardasil 9) protect against 9 types of HPV, including types 16 and 18, which cause most cervical cancers.
• But there are other high-risk HPV types that the vaccine doesn’t cover.
• So there’s still a small chance of developing abnormal cervical cells.
2. The vaccine is preventive, not a treatment
• It doesn’t clear an existing infection or treat abnormal cells if they already exist.
• If you were already exposed to HPV before getting vaccinated, the vaccine won’t reverse that.
3. Screening finds problems early — even if you’re low risk
• Even vaccinated people can have other risk factors (like smoking, immune issues, or early sexual activity) that increase the chance of cervical changes.
Summary
HPV vaccine Still need screening? Why?
Yes Yes Vaccine doesn't cover all HPV types; screening catches issues early
Screening schedule (if vaccinated):
• Ages 21–29: Pap smear every 3 years
• Ages 30–65: Pap smear every 3 years, or HPV test (or co-test) every 5 years
Let me know if you’d like to go over your personal risk factors or help plan when to get screened next.

AI: Artificial intelligence, HPV: Human papillomavirus, DES: Diethylstilbestrol.

Based on the interaction, ChatGPT offered well-formulated responses in simple language without complex medical vocabulary. Notably, ChatGPT attempts to engage patients with empathetic, open-ended prompts, such as “let me know if you’d like to go over your personal risk factors or help plan when to get screened next,” which may support patient education and facilitate discussion for patients who are shy or uncertain. However, potential risks include misinformation, lack of source citation, and medico-legal considerations, which must be considered when integrating AI tools into clinical practice. While these AI-generated responses do not replace professional medical guidance, they demonstrate the potential to improve patient-centred education. A thoughtful way forward would be to embrace AI tools responsibly to enhance clinical communication and patient education.

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

Patient’s consent is not required as there are no patients in this study.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The author confirms that they have used artificial intelligence (AI)-assisted technology, specifically generative AI (ChatGPT version 4), to generate example responses to common patient queries related to cervical cancer screening. All outputs were critically reviewed, interpreted, and contextualised by the author, who takes full responsibility for the final content of the manuscript.

References

  1. , , , , . Human papillomavirus infection and cervical cancer: Epidemiology, screening, and vaccination-Review of current perspectives. J Oncol. 2019;2019:3257939.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , , . Carcinogenesis and management of human papillomavirus-associated cervical cancer. Int J Clin Oncol. 2023;28:965-74.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , , , , et al. Cervical cancer: A global health crisis. Cancer. 2017;123:2404-12.
    [CrossRef] [PubMed] [Google Scholar]
  4. . ChatGPT: A comprehensive review on background, applications, key challenges, bias, ethics, limitations and future scope. Internet Things Cyberphys Syst. 2023;3:121-54.
    [CrossRef] [Google Scholar]
  5. , , . Utility of ChatGPT in clinical practice. J Med Internet Res. 2023;25:e48568.
    [CrossRef] [PubMed] [Google Scholar]

Fulltext Views
304

PDF downloads
22
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections